Your browser doesn't support javascript.
loading
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.
Terpos, Evangelos; Gavriatopoulou, Maria; Ntanasis-Stathopoulos, Ioannis; Briasoulis, Alexandros; Gumeni, Sentiljana; Malandrakis, Panagiotis; Fotiou, Despina; Papanagnou, Eleni-Dimitra; Migkou, Magdalini; Theodorakakou, Foteini; Roussou, Maria; Eleutherakis-Papaiakovou, Evangelos; Kanellias, Nikolaos; Trougakos, Ioannis P; Kastritis, Efstathios; Dimopoulos, Meletios A.
Afiliação
  • Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. eterpos@med.uoa.gr.
  • Gavriatopoulou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Ntanasis-Stathopoulos I; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Briasoulis A; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Gumeni S; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Malandrakis P; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Fotiou D; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Papanagnou ED; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Migkou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Theodorakakou F; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Roussou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Eleutherakis-Papaiakovou E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Kanellias N; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Trougakos IP; Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Blood Cancer J ; 11(8): 138, 2021 08 02.
Article em En | MEDLINE | ID: mdl-34341335
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos